Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
ESMO Open
|
October 1, 2024
Phase I/II study of nivolumab plus lenvatinib for advanced biliary tract cancer (JCOG1808/NCCH1817, SNIPE)
M Ueno, C Morizane, M Ikeda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2018
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
K Shitara, T Yamanaka, T Denda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
M Ikeda, S Shimizu, T Sato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2017
Reply to the Letter to the editor 'Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus Sorafenib for advanced hepatocellular carcinoma: randomized phase II trial' by Fornaro et al
M Ikeda, S Shimizu, T Sato, et al.
Investigational New Drugs
|
December 16, 2014
Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer
Masato Matsuyama, H Ishii, J Furuse, et al.
The Pharmacogenomics Journal
|
December 24, 2008
A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studies
Y Sato, N M Laird, K Nagashima, et al.
International Journal of Clinical Practice
|
November 29, 2013
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis
R Lencioni, M Kudo, S-L Ye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
M Ueno, T Okusaka, Y Omuro, et al.
British Journal of Cancer
|
January 13, 2017
Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer
T Ioka, Y Komatsu, N Mizuno, et al.
International Journal of Clinical Practice
|
June 16, 2012
First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study
R Lencioni, M Kudo, S-L Ye, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
ESMO Open
|
October 1, 2024
Phase I/II study of nivolumab plus lenvatinib for advanced biliary tract cancer (JCOG1808/NCCH1817, SNIPE)
M Ueno, C Morizane, M Ikeda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2018
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
K Shitara, T Yamanaka, T Denda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2016
Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
M Ikeda, S Shimizu, T Sato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2017
Reply to the Letter to the editor 'Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus Sorafenib for advanced hepatocellular carcinoma: randomized phase II trial' by Fornaro et al
M Ikeda, S Shimizu, T Sato, et al.
Investigational New Drugs
|
December 16, 2014
Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer
Masato Matsuyama, H Ishii, J Furuse, et al.
The Pharmacogenomics Journal
|
December 24, 2008
A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studies
Y Sato, N M Laird, K Nagashima, et al.
International Journal of Clinical Practice
|
November 29, 2013
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis
R Lencioni, M Kudo, S-L Ye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
M Ueno, T Okusaka, Y Omuro, et al.
British Journal of Cancer
|
January 13, 2017
Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer
T Ioka, Y Komatsu, N Mizuno, et al.
International Journal of Clinical Practice
|
June 16, 2012
First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study
R Lencioni, M Kudo, S-L Ye, et al.
Page
of 6